{"entity":{"id":"04871bed-7d3a-5127-9644-ef8879ec85f4","name":"Atlantic Laboratories Limited","type":"Organization","kind":"company","jurisdiction":"BM","identifier":"icij:icijol-80000538","risk":"MED","flags":[]},"identity":{"linked_records":[{"id":"20aa872f-1f08-5a6a-9579-5bdee0d97582","name":"Atlantic Laboratories Limited","jurisdiction":"BM","identifier":"icij:icijol-82000538","registry":"icij_offshoreleaks"},{"id":"c47ba712-0bb6-54ac-a192-2b1224b31b7c","name":"Atlantic Laboratories Limited","jurisdiction":"BM","identifier":"lei:254900IPO2N7DAG1DH34","registry":"gleif"}],"also_known_in":["icij_offshoreleaks","gleif"]},"ownership":{"direct_owners":[],"holdings":[{"role":"shareholder of","share":null,"asset":{"id":"9d9e2fe9-e425-5eb5-a24a-f3303a1b3c84","name":"Mundipharma Pharmaceutical Company","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"MED","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"icij_offshoreleaks","source_url":"https://offshoreleaks.icij.org/nodes/80000538"}],"source":"corpus"}